Seismic velocities of CaSiO3 perovskite can explain LLSVPs in Earth's lower mantle.

Seismology records the presence of various heterogeneities throughout the lower mantle1,2, but the origins of these signals-whether thermal or chemical-remain uncertain, and therefore much of the information that they hold about the nature of the deep Earth is obscured. Accurate interpretation of observed seismic velocities requires knowledge of the seismic properties of all of Earth's possible mineral components. Calcium silicate (CaSiO3) perovskite is believed to be the third most abundant mineral throughout the lower mantle. Here we simultaneously measure the crystal structure and the shear-wave and compressional-wave velocities of samples of CaSiO3 perovskite, and provide direct constraints on the adiabatic bulk and shear moduli of this material. We observe that incorporation of titanium into CaSiO3 perovskite stabilizes the tetragonal structure at higher temperatures, and that the material's shear modulus is substantially lower than is predicted by computations3-5 or thermodynamic datasets6. When combined with literature data and extrapolated, our results suggest that subducted oceanic crust will be visible as low-seismic-velocity anomalies throughout the lower mantle. In particular, we show that large low-shear-velocity provinces (LLSVPs) are consistent with moderate enrichment of recycled oceanic crust, and mid-mantle discontinuities can be explained by a tetragonal-cubic phase transition in Ti-bearing CaSiO3 perovskite.

First-principles constraints on diffusion in lower-mantle minerals and a weak D'' layer.

Post-perovskite MgSiO(3) is believed to be present in the D'' region of the Earth's lowermost mantle. Its existence has been used to explain a number of seismic observations, such as the D'' reflector and the high degree of seismic anisotropy within the D'' layer. Ionic diffusion in post-perovskite controls its viscosity, which in turn controls the thermal and chemical coupling between the core and the mantle, the development of plumes and the stability of deep chemical reservoirs. Here we report the use of first-principles methods to calculate absolute diffusion rates in post-perovskite under the conditions found in the Earth's lower mantle. We find that the diffusion of Mg(2+) and Si(4+) in post-perovskite is extremely anisotropic, with almost eight orders of magnitude difference between the fast and slow directions. If post-perovskite in the D'' layer shows significant lattice-preferred orientation, the fast diffusion direction will render post-perovskite up to four orders of magnitude weaker than perovskite. The presence of weak post-perovskite strongly increases the heat flux across the core-mantle boundary and alters the geotherm. It also provides an explanation for laterally varying viscosity in the lowermost mantle, as required by long-period geoid models. Moreover, the behaviour of very weak post-perovskite can reconcile seismic observation of a D'' reflector with recent experiments showing that the width of the perovskite-to-post-perovskite transition is too wide to cause sharp reflectors. We suggest that the observed sharp D'' reflector is caused by a rapid change in seismic anisotropy. Once sufficient perovskite has transformed into post-perovskite, post-perovskite becomes interconnected and strain is partitioned into this weaker phase. At this point, the weaker post-perovskite will start to deform rapidly, thereby developing a strong crystallographic texture. We show that the expected seismic contrast between the deformed perovskite-plus-post-perovskite assemblage and the overlying isotropic perovskite-plus-post-perovskite assemblage is consistent with seismic observations.

Dose confirmation studies for monepantel, an amino-acetonitrile derivative, against fourth stage gastro-intestinal nematode larvae infecting sheep.

Monepantel is the first compound from the recently discovered amino-acetonitrile derivative (AAD) class of anthelmintics to be developed for use in sheep. Nine dose confirmation studies were conducted in Australia, New Zealand and Switzerland to confirm the minimum therapeutic oral dose of monepantel to control fourth stage (L4) gastro-intestinal nematode larvae in sheep (target species were Haemonchus contortus, Teladorsagia (Ostertagia) circumcincta, Teladorsagia trifurcata, Trichostrongylus axei, Trichostrongylus colubriformis, Trichostrongylus vitrinus, Cooperia curticei, Cooperia oncophora, Nematodirusbattus, Nematodirusfilicollis, Nematodirus spathiger, Chabertia ovina and Oesophagostomum venulosum). In each study, sheep infected with a defined selection of the target nematodes were treated with 2.5mg monepantel/kg liveweight. Following euthanasia and worm counting, efficacy was calculated against worm counts from untreated control groups. The results demonstrate high (95<100%) efficacy of monepantel when administered orally to sheep at 2.5mg/kg for most species tested. Efficacy levels against N. spathiger and O. venulosum were variable and failed to meet the required regulatory standard (> or =90%) in some studies. Efficacy was demonstrated against L4 stages of nematodes known to be resistant to either benzimidazole and/or levamisole anthelmintics (macrocyclic lactone resistant isolates were not available for testing). The broad-spectrum activity of monepantel against L4 larvae of common gastro-intestinal nematodes in sheep and its favorable safety profile represents a significant advance in the treatment of parasitic gastro-enteritis in this animal species. No adverse effects related to treatment with monepantel were observed.

Use of a uterine pessary to prevent infection of the uterus of the cow after parturition.

A uterine pessary containing penicillin, streptomycin, formosulphathiazole and ethinyloestradiol, was assessed for its efficacy in reducing the frequency and severity of uterine infections in cows after parturition. Fifteen pluriparous Holstein Friesian cows had pessaries inserted into the uterus within 24 hours after calving. Compared with 14 similar untreated cows there were significant reductions in the number infected by Actinomyces pyogenes and in the number exhibiting abnormal uterine discharges.

European field study of the efficacy and safety of the novel anthelmintic monepantel in sheep.

During 2007, a large-scale controlled, multicentre, blinded and randomised field study was conducted in Scotland, England and France to assess the efficacy and safety of monepantel, the first molecule to be developed from the recently discovered amino-acetonitrile derivatives class of anthelmintics, in sheep. Monepantel was administered orally, at a minimum dose of 2.5 mg/kg bodyweight, for the control of gastrointestinal nematodes in sheep maintained at pasture in a range of commercial production systems. Efficacy was measured by faecal egg count (FEC) reduction tests seven days after treatment and was demonstrated to be over 98 per cent against mixed-genus infections. The reduction in FEC of monepantel-treated sheep was statistically significantly greater than in untreated control sheep (P<0.0001). The efficacy of monepantel against mixed-genus natural field infections of the major gastrointestinal nematodes was in agreement with similar studies conducted in Australia and New Zealand. There were no treatment-related adverse events during the study, which included the use of a range of concomitant treatments.